Liana Moussatos Joins A Slew of Analysts That Are Gaining More Confidence in Xoma
A Peek Into Three Volatile Biotech Stocks: ADMS, XOMA, KMDA
XOMA Corporation (NASDAQ: XOMA) announced several corporate actions to further streamline its operations to focus on XOMA 358 clinical development, monetize non-core assets, …
XOMA Corp (NASDAQ:XOMA) shares are surging forward a sturdy 5% today after delivering its third-quarter financial results. Yet, considering the biotech firm’s pipeline …
Analysts from BTIG and Webush are sharing insights on two falling stocks: Imperva Inc (NYSE:IMPV), whose shares are crashing close to 15% today, and …
XOMA Corp (NASDAQ:XOMA) announced the United Kingdom’s Medicines and Healthcare Products Regulatory Agency (MHRA) has accepted in principle the Company’s proposal to initiate a …
XOMA Corp (NASDAQ:XOMA) recently released initial data from its single-dose trials for XOMA 358, the firm’s pipeline drug designed to treat rare endocrine …
Analysts are weighing in on Novavax, Inc. (NASDAQ:NVAX) and XOMA Corp (NASDAQ:XOMA), as shares of both companies fell sharply today due to various …
XOMA Corp (NASDAQ:XOMA) provided an update on its ongoing XOMA 358 Phase 2 studies in patients with severe hypoglycemia due to congenital hyperinsulinism (CHI) …
XOMA Corp (NASDAQ:XOMA) just ended its second quarter, and yet, all eyes are on the biotech company’s endocrinology portfolio, specifically XOMA 358, a …
